The results of a recent national study conducted by the Arkansas Agricultural Experiment Station found that the weight loss drugs known as Glucagon-like peptide-1 agonists — GLP-1s — lead to new food and drink consumption patterns, which underscore observed changes in food and beverage marketing. While previous consumer behavior studies have shown GLP-1s caused lower preference for high-fat foods and promoted weight loss, there has been limited information on how it influenced food preferences and consumption behavior across different food categories. For the study, they surveyed current, previous and potential consumers of GLP-1s to better understand how taking these medications affects food choices. The study also included people who did not plan to take a GLP-1.

“Attention, Shoppers!” by MIT political scientist Kathleen Thelen examines the political history and dynamics behind how large American retailers got so large.